This study aims to better understand sarcoidosis, a disease that causes inflammation in organs, most commonly the lungs. Researchers want to create tools to predict how sarcoidosis will progress in patients. They will do this by looking at clinical information gathered during regular doctor visits and by analyzing blood samples. The study will measure changes in your forced vital capacity (FVC), which is how much air you can exhale after a deep breath, at the beginning and after 24 months. You may be able to join if you are an adult (19 years or older) with a confirmed diagnosis of sarcoidosis. The study is currently unclear on its recruitment status and plans to enroll 200 participants.

Study design

This is an observational study, meaning participants will be monitored without receiving a specific intervention. It plans to enroll 200 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 24 months to measure changes in their forced vital capacity.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.